The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Seth Sandesh since year 2005.
The trader's CIK number is 1566175.
At the time of this reporting, Seth Sandesh is the CEO of Actinium Pharmaceuticals, Inc. .
(stock ticker symbol ATNM).
See this page for all insider trading activities at Actinium Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-07-17||ATNM||Actinium Pharmaceuticals, Inc.||Buy||10,000||.79||7,900|
|2018-04-19||ATNM||Actinium Pharmaceuticals, Inc.||Buy||5,000||.38||1,900|
|2017-08-02||ATNM||Actinium Pharmaceuticals, Inc.||Buy||33,333||.75||24,999|
|2017-06-15||ATNM||Actinium Pharmaceuticals, Inc.||Buy||7,500||1.17||8,737|
|2016-12-30||ATNM||Actinium Pharmaceuticals, Inc.||Buy||5,000||.88||4,400|
|2016-12-12||ATNM||Actinium Pharmaceuticals, Inc.||Buy||5,000||.98||4,900|
|2016-04-14||ATNM||Actinium Pharmaceuticals, Inc.||Buy||5,000||2.00||10,000|
|2016-04-15||ATNM||Actinium Pharmaceuticals, Inc.||Buy||3,500||2.00||7,017|
|2016-04-18||ATNM||Actinium Pharmaceuticals, Inc.||Buy||6,500||1.99||12,902|
|2015-12-15||RLMD||Relmada Therapeutics, Inc.||Buy||9,500||3.23||30,666|
|2015-12-14||RLMD||Relmada Therapeutics, Inc.||Buy||10,500||2.82||29,620|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Seth Sandesh (CEO of Actinium Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.